je.st
news
Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals
2015-11-08 00:21:39| Biotech - Topix.net
Leerink Swann issued their Q4 2016 earnings per share estimates for Regeneron Pharmaceuticals in a report issued on Thursday, Zacks reports. Leerink Swann analyst J. Schwartz expects that the brokerage will post earnings of $2.79 per share for the quarter.
Tags: issues
estimate
earnings
pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||